IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 142 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $118,000 | +21.6% | 7,400 | 0.0% | 0.03% | +16.7% |
| Q2 2016 | $97,000 | +19.8% | 7,400 | 0.0% | 0.02% | +14.3% |
| Q1 2016 | $81,000 | +62.0% | 7,400 | +54.2% | 0.02% | +61.5% |
| Q3 2015 | $50,000 | -13.8% | 4,800 | 0.0% | 0.01% | -7.1% |
| Q2 2015 | $58,000 | -24.7% | 4,800 | 0.0% | 0.01% | -22.2% |
| Q1 2015 | $77,000 | +24.2% | 4,800 | 0.0% | 0.02% | +28.6% |
| Q3 2014 | $62,000 | +44.2% | 4,800 | +71.4% | 0.01% | +40.0% |
| Q2 2014 | $43,000 | +26.5% | 2,800 | 0.0% | 0.01% | +11.1% |
| Q1 2014 | $34,000 | +3.0% | 2,800 | 0.0% | 0.01% | +12.5% |
| Q4 2013 | $33,000 | 0.0% | 2,800 | 0.0% | 0.01% | -11.1% |
| Q3 2013 | $33,000 | +17.9% | 2,800 | 0.0% | 0.01% | +12.5% |
| Q2 2013 | $28,000 | – | 2,800 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $157,835,700 | 21.26% |
| AlphaCentric Advisors LLC | 292,500 | $2,816,775 | 1.60% |
| Quantedge Capital Pte Ltd | 179,900 | $1,732,437 | 0.94% |
| Intrinsic Value Partners, LLC | 50,355 | $484,919 | 0.62% |
| Brown Capital Management | 3,719,796 | $35,821,635 | 0.55% |
| ARMISTICE CAPITAL, LLC | 3,456,000 | $33,281,280 | 0.51% |
| SummerHaven Investment Management, LLC | 67,765 | $652,577 | 0.48% |
| BRAIDWELL LP | 1,348,099 | $12,982,193 | 0.41% |
| AFFINITY INVESTMENT ADVISORS, LLC | 50,733 | $488,559 | 0.32% |
| EMC Capital Management | 43,315 | $417 | 0.31% |